Your browser doesn't support javascript.
loading
The psychedelic call: analysis of Australian Poisons Information Centre calls associated with classic psychedelics.
Wilkes, Rachael; Roberts, Darren M; Liknaitzky, Paul; Brett, Jonathan.
Afiliación
  • Wilkes R; Emergency Department, St. Vincent's Hospital, Sydney, Australia.
  • Roberts DM; Edith Collins Centre, Drug Health Services, Royal Prince Alfred Hospital, Sydney, Australia.
  • Liknaitzky P; New South Wales Poison's Information Centre, Sydney Children's Hospitals Network, Westmead, Sydney, Australia.
  • Brett J; St. Vincent's Clinical School, University of New South Wales, Sydney, Australia.
Clin Toxicol (Phila) ; 62(4): 242-247, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38753585
ABSTRACT

INTRODUCTION:

The global use of certain classical psychedelics has increased in recent years, but little is known about their spectrum of toxicity within Australia. We aim to describe calls to New South Wales Poisons Information Centre relating to exposures to classical psychedelics including lysergic acid diethylamide, psilocybin, N,N-dimethyltryptamine, ayahuasca, mescaline and ibogaine.

METHODS:

This is a retrospective observational study of calls to New South Wales Poisons Information Centre between January 2014 and December 2022. We identified exposures to classical psychedelics within New South Wales Poisons Information Centre database and measured the annual number of exposures, source of call (hospital, health care worker, member of the public), co-ingested substances, clinical features and advice given.

RESULTS:

There were 737 calls related to relevant psychedelic exposures; 352 (47.8 per cent) to lysergic acid diethylamide, 347 (47.0 per cent) to psilocybin, 28 (3.8 per cent) to N,N-dimethyltryptamine, 4 (0.5 per cent) to ayahuasca, 4 (0.5 per cent) to mescaline and 2 (0.3 per cent) to ibogaine. Cases were predominantly male (77.2 per cent) and aged between 20 and 74 years (65.6 per cent). Psychedelic calls more than doubled from 45 in 2014 to 105 in 2022 and 625 (85 per cent) of all calls were either from or referred to hospital. Co-ingestion of psychedelics with another substance occurred in 249 (33.8 per cent) of calls and the most frequent clinical features related to single substance psychedelic exposures were hallucinations (27.6 per cent), gastrointestinal symptoms (21.7 per cent) and tachycardia (18.1 per cent). Seizures occurred in 2.9 per cent of single substance psychedelic exposures.

DISCUSSION:

Increasing incidence of psychedelic exposure calls, including those reporting significant toxicity, likely reflects increasing community use. This may in part be driven by increasing interest in psychedelic assisted psychotherapy trials subsequently increasing public awareness.

CONCLUSION:

Relatively high poisoning severity contrasts with safety within clinical trials of psychedelic assisted psychotherapy that may relate to the uncontrolled nature of community use which is mitigated within clinical trial environments. Education about safe use may be useful.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Centros de Control de Intoxicaciones / Alucinógenos Límite: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged País/Región como asunto: Oceania Idioma: En Revista: Clin Toxicol (Phila) Asunto de la revista: TOXICOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Centros de Control de Intoxicaciones / Alucinógenos Límite: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged País/Región como asunto: Oceania Idioma: En Revista: Clin Toxicol (Phila) Asunto de la revista: TOXICOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Reino Unido